Work

The Role of Artificial Intelligence in Revolutionizing Endometriosis Diagnosis and Clinical Pathology: A Commentary Review of New Biomarkers (2020–2026)

Year: 2026
Type: article
Abstract: The diagnosis of endometriosis has historically been hampered by an average diagnostic delay of seven to ten years, owing largely to the field's reliance on invasive surgical laparoscopy as the "gold standard."The integration of artificial intelligence (AI) and machine learning (ML) into clinical pathology, however, is now catalyzing a paradigm shift toward non-invasive, precision diagnostics.This report synthesizes research published between 2020 and 2026, highlighting the emergence of high-accuracy diagnostic tools built on microRNA (miRNA) signatures, plasma protein panels, and genomic markers.Key findings include the validation of blood-and saliva-based miRNA signatures achieving area under the curve (AUC) values exceeding 0.95, rivaling the accuracy of surgical diagnosis.AI methodologies including Random Forest, eXtreme Gradient Boosting (XGBoost), and support vector machines (SVM) have identified novel biomarkers such as PNMA2, LRP1, and WISP2/CCN5.These advances promise not only to shorten diagnostic latency but also to enable molecular stratification, supporting more personalized treatment strategies.Challenges remain in clinical standardization and in validating certain protein-based models, yet the accumulated evidence suggests that AI-driven clinical pathology will soon augment and in some cases replace traditional surgical diagnosis for many patients.
Author: Raouf Roshdy
Language: English
Field: Medicine
Open Access status: diamond
OpenAlex ID: W7204939195
FWCI:
Cites: 32
Cited by:
Related to: 10